Curanex Pharmaceuticals Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

238.51M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	26.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CURX News

14 days ago - Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline - GlobeNewsWire
16 days ago - Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care - GlobeNewsWire
20 days ago - Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company - GlobeNewsWire
22 days ago - Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission - GlobeNewsWire
5 weeks ago - Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission - GlobeNewsWire
5 weeks ago - Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - GlobeNewsWire
6 weeks ago - Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - GlobeNewsWire
6 weeks ago - Curanex Forms World Class Scientific Advisory Board - GlobeNewsWire

More News